Adult

Fidaxomicin

Warning

General Information

Macrocyclic antibiotic

Restricted formulary antimicrobial: For details see OUH netFormulary

AWaRe antibiotic classification: 'Watch'. Use as per guidelines. All other indications to be discussed with Micro/ID.

For all information regarding interactions, contraception, pregnancy and breastfeeding and additional information, see BNF and Summary of Product Characteristics (SPC).

Standard dose

 

Oral dose

Clostridioides difficile infection

200mg BD for 10 days

For patients with an enteral feeding tube or swallowing difficulties order fidaxomicin liquid from pharmacy.

Renal and hepatic impairment

Renal impairment

No dose adjustment required. 

Severe renal impairment: Use with caution.

Unlikely to be dialysed. 

 

Hepatic impairment

No dose adjustment required.

Moderate to severe hepatic impairment: Use with caution due to limited clinical data in this population.

References

  1. Tillotts Pharma UK Limited. Fidaxomicin 200mg film-coated tablets summary of product characteristics. Electronic medicines compendium. Last revision of the text 05/01/23. Accessed via www.medicines.org.uk Accessed 23/3/26.
  2. British National Formulary. Fidaxomicin. BNF online accessed via www.medicinescomplete.com  Accessed 23/3/26.
  3. The Renal Drug Database. Fidaxomicin. Last updated 23/9/24. Accessed via https://renaldrugdatabase.com Accessed 23/3/26.
  4. Sanford Guide [online]. Fidaxomicin. Last updated 13/3/26. Accessed via https://webedition.sanfordguide.com Accessed 23/3/26.

Editorial Information

Last reviewed: 23 Mar 2026

Next review date: 28 Mar 2029

Author(s): AMST.